# Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy

> **NCT02278692** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 26 (actual)

## Conditions studied

- Calciphylaxis
- Calcific Uremic Arteriolopathy

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02278692
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02278692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02278692, "Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02278692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*